Cell Line Engineering for Production of Therapeutic Antibody Glycoforms with Increased Biological Activity

  • Pablo Umana
  • Peter Bruenker
  • Claudia Ferrara
  • Samuel Moser
  • Tobias Suter
  • Christian Gerdes
  • Ursula Puentener
  • Joel Jean-Mairet
  • Patrick Buholzer
  • Manuel Spaeni
Conference paper

DOI: 10.1007/1-4020-3103-3_82

Part of the ESACT Proceedings book series (ESACT, volume 2)
Cite this paper as:
Umana P. et al. (2005) Cell Line Engineering for Production of Therapeutic Antibody Glycoforms with Increased Biological Activity. In: Gòdia F., Fussenegger M. (eds) Animal Cell Technology Meets Genomics. ESACT Proceedings, vol 2. Springer, Dordrecht

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer 2005

Authors and Affiliations

  • Pablo Umana
    • 1
  • Peter Bruenker
    • 1
  • Claudia Ferrara
    • 1
  • Samuel Moser
    • 1
  • Tobias Suter
    • 1
  • Christian Gerdes
    • 1
  • Ursula Puentener
    • 1
  • Joel Jean-Mairet
    • 1
  • Patrick Buholzer
    • 1
  • Manuel Spaeni
    • 1
  1. 1.GLYCART BiotechnologyZurichSwitzerland

Personalised recommendations